Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
[Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis].
Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System.
Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS.
Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis.
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman.
Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study.
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Abnormalities of the executive control network in multiple sclerosis phenotypes: An fMRI effective connectivity study.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Ranking of Disease-Modifying Therapies for Multiple Sclerosis.
Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord.
Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis.
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.
Vitamin D and multiple sclerosis-from epidemiology to prevention.
Serostatus of Epstein-Barr virus in Iranian MS patients.
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Pages
« first
‹ previous
…
679
680
681
682
683
684
685
686
687
…
next ›
last »